News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Celgene Corporation (CELG) Prices $1.5 Billion of Senior Unsecured Notes


8/2/2013 9:33:07 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SUMMIT, N.J.--(BUSINESS WIRE)--Celgene Corporation (NASDAQ: CELG) today announced the successful pricing of three series of senior unsecured notes for an aggregate principal amount of $1,500 million. Of these notes, $400 million will mature in 2018 and will bear interest at an annual rate of 2.300%; $700 million will mature in 2023 and will bear interest at an annual rate of 4.000% and $400 million will mature in 2043 and will bear interest at an annual rate of 5.250%. The 2.300% notes due 2018, the 4.000% notes due 2023 and the 5.250% notes due in 2043 were priced to yield 2.344%, 4.067% and 5.307%, respectively.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES